Alpha Tau Medical Ltd. (DRTS): Capital Expenditures

Annual figures by period end, from SEC filings.

$6.08M
Year ended 2025-12-31
+88.7%
3-year compound annual growth
+10.0%
5-year compound annual growth
$6.40M2019-12-31: $1.29M2020-12-31: $3.77M2021-12-31: $2.93M2022-12-31: $904.0K2023-12-31: $6.40M2024-12-31: $2.24M2025-12-31: $6.08M$6.08M
2019-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$6.08M+171.4%2026-03-09, From 2025-01-01
2024-12-31$2.24M-65.0%2026-03-09, From 2024-01-01
2023-12-31$6.40M+608.1%2026-03-09, From 2023-01-01
2022-12-31$904.0K-69.1%2025-03-12, From 2022-01-01
2021-12-31$2.93M-22.3%2024-03-07, From 2021-01-01
2020-12-31$3.77M+191.3%2023-03-09, From 2020-01-01
2019-12-31$1.29Mn/a2022-03-28, From 2019-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Alpha Tau Medical Ltd. (DRTS)2025-12-31$6.08M+171.4%
NeuroPace Inc (NPCE)2025-12-31$332.0K+8.5%
CVRx, Inc. (CVRX)2025-12-31$580.0K-57.4%
Iradimed Corp (IRMD)2025-12-31$7.76M-3.0%
DarioHealth Corp. (DRIO)2025-12-31$142.0K+2.9%
InfuSystem Holdings, Inc (INFU)2025-12-31$560.0K-48.7%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$522.0K+89.8%
EBR Systems, Inc. (NONE.)2025-12-31$3.68Mn/m
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$489.0K+69.2%

Compare DRTS, NPCE, CVRX, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗